1
|
PEG77
|
(KIAALKE)3G
|
Fmoc solid phase synthesis
|
6
|
soluble protein N/A
|
random coil
|
DMF/PBS
|
CD, DLS, cryo-TEM
|
N/A
|
nanomaterials
|
Marsden et al., 2008
|
2
|
PS11
|
G(EIAALEK)3
|
Fmoc solid phase synthesis
|
3.3
|
spherical
|
α-helix
|
DMF/PBS
|
CD, DLS, cryo-TEM
|
15 ± 2 nm
|
nanomaterials
|
Marsden et al., 2008
|
3
|
PS - PEG
|
G(EIAALEK)3/(KIAALKE)3G
|
Fmoc solid phase synthesis
|
9.1
|
rod-like
|
coiled-coil
|
DMF/PBS
|
CD, DLS, cryo-TEM
|
L = 42 ± 10 nm; W = 8 ± 1 nm
|
nanomaterials
|
Marsden et al., 2008
|
4
|
PEG
|
IDFISTYITKIDKKIQSIEDIIHQIENKISEIKQLIK
|
Fmoc solid phase synthesis followed by cystein-maleimide chemistry
|
8.1 and 1.2
|
hydrogel
|
α-helix to coiled-coil
|
PBS
|
CD, AUC
|
N/A
|
engineering, controlled therapeutic release, and in vitro cell expansion
|
Jing et al., 2008
|
5
|
PEG
|
GEAK(LAEIAK)2LAEIYA
|
Fmoc solid phase peptide synthesis followed by Pegylation
|
3.3 and 4.2
|
thin layers of aggregates with nanosized features
|
α-helical coiled-coil motif
|
PBS
|
CD, AUC, EPR, AFM
|
H = 1 nm; D = 10 nm
|
nanomaterials
|
Vandermeulen et al., 2004; Vandermeulen et al., 2003
|
6
|
PEG3400
|
IEEEVEKEVQRLEFEVQALEKEVAEYQEGI and TEEEVRKRVQRLRFRVQALRKRVAEYQEGI
|
Fmoc solid phase peptide synthesis followed by PEGylation
|
m = 15; Mw >100kDa
|
micelles, hydrogels
|
α-helix, coiled-coil
|
PBS
|
CD, AUC, DLS, SLS
|
Rh = 55 nm; Rg = 62 nm
|
hydrogels, drug delivery systems
|
Sahin and Kiick, 2009
|
7
|
(HPMA) and (DAMA)
|
6H-(random coil block)-(VSSLESK)6
|
Genetic Engineering
|
1 block 1 peptide
|
hydrogel
|
α-helix to coiled coil
|
PBS
|
CD
|
N/A
|
drug delivery systems
|
Tang et al., 2001
|